Short description
Clinical-stage therapeutics company with a computational deep learning peptide design platform • Design > discovery
Description
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Pittsburgh, Pennsylvania, United States, North America
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccessforu, Noaccess, Uh Ohhhh, Noaccessforu, Noaccess, Noaccess, Nopepepe, Uh Ohhhh, Absolutely Noaccess, Nopepepe, No Way
Sign in for full access
Founders
Jonathan Steckbeck, Ron Montelaro